Anaphylaxis to sublingual immunotherapy.
Dunsky
E H
EH
The Asthma Center 205 North Broad Street Suite 300 Philadelphia, PA 19107, USA. gpike35@aol.com
Goldstein
M F
MF
Dvorin
D J
DJ
Belecanech
G A
GA
D000286:Administration, Sublingual; D000328:Adult; D000485:Allergens / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D000528:Alternaria / Q000276:immunology; D031164:Ambrosia / Q000276:immunology; D000707:Anaphylaxis / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000628:therapy; D002415:Cats; D004285:Dogs; D004848:Epithelium / Q000276:immunology; D005260:Female; D006197:Hair / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D006109:Poaceae / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D011537:Pruritus / Q000209:etiology / Q000628:therapy; D013997:Time Factors; D016896:Treatment Outcome
D000485:Allergens; D000893:Anti-Inflammatory Agents; D011241:Prednisone